Peds Sanofi H1N1 Influenza Vaccine Administered at Two Dose Levels

NCT00944073 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

583

Enrollment

NIH

Sponsor class

Conditions

Influenza

Interventions

BIOLOGICAL: Influenza Virus Vaccine, Monovalent A/H1N1 A/California/7/2009 NYMC X-179A

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)